Cell line · CVCL_0002
Papers194
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 194
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| IL10RB-AS1 promotes pro-caspase-1-dependent pyroptosis via regulating the oligomerization and nucleation of CARD8 C-terminal domain to suppress acute myeloid leukemia. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Biological Activities and Phytochemical Composition of Arum rupicola var. rupicola: An In Vitro and In Silico Study. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cytotoxicity and α-Amylase Inhibitory Activities of Limonoids From the Leaves of Azadirachta indica. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Verrucacrylic Acids A and B From a Marine Sponge-derived Verrucosispora sp. FIM06025. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Synthesis, Characterization, In Vitro and In Silico Investigation of Azo-Based Co(III), Zn(II), and Pd(II) Complexes Against Human Leukemia. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Elevated neutrophil extracellular traps formation driven by the HPV-mediated CXCL8-CXCR1/2-ROS-p21 axis promotes the growth and metastasis of cervical cancer. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bone marrow stromal cells promote chemoresistance in acute myeloid leukaemia through P2RX7-mediated antioxidant defence. | Exp Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MYDGF as a telomerase activator and therapeutic target for osteoarthritis. | Adv Biotechnol (Singap) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Novel noscapine derivative induces AML differentiation by dual-engaging DHODH and mitochondrial lipids to trigger a metabolic-epigenetic-transcriptional cascade. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Oxygen-stable streptolysin O variant enables mitochondrial ATP synthesis analysis in minimal cells blood and tissues. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A structure-based modeling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intracellular iron homeostasis-regulated epigenetic reprogramming contributes to -7/del(7q) leukemia. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Single-Dose Bundibugyo Virus Vaccine Protects Macaques Within 3 Days. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Micro-Galvanic Coupling Programs the Therapeutic Zinc Ion Window to Reconfigure Immune Cascades for Pro-Regenerative Bone Healing. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative multi-omics, machine learning, and experimental validation reveal that TPM1 suppresses M2 macrophage polarization and enhances chemosensitivity in acute myeloid leukemia. | Cell Biol Toxicol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LDLRAD2 drives glycolysis and angiogenesis to promote extramedullary infiltration in acute myeloid leukemia. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cytotoxic Profiling of 3',4',5'-Trimethoxychalcones Reveals Cell-Line-Dependent Cytotoxic Activity: An In Vitro and In Silico Study. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0002/papers